Amoxicillin 500 mg Three Times Daily Dosing
Amoxicillin 500 mg three times daily (TID) is a valid dosing regimen for adults with mild to moderate respiratory tract infections, though twice-daily dosing at higher doses (875 mg BID) is now preferred for most indications due to improved compliance and equivalent efficacy.
Standard Adult Dosing Recommendations
The FDA-approved dosing for amoxicillin varies by infection severity 1:
For mild to moderate infections:
- 500 mg every 8 hours (TID), OR
- 250 mg every 8 hours for less severe cases
For severe infections or lower respiratory tract infections:
- 875 mg every 12 hours (BID), OR
- 500 mg every 8 hours (TID)
Clinical Context and Guideline Support
Group A Streptococcal Pharyngitis
For strep throat, the IDSA guidelines recommend 500 mg twice daily (BID) rather than TID dosing 2, 3. The BID regimen provides equivalent efficacy with better adherence.
Community-Acquired Pneumonia
For outpatient CAP with comorbidities, high-dose amoxicillin is recommended: 1 gram three times daily (not 500 mg TID) when used as monotherapy or combined with a macrolide 4. The 500 mg TID dose would be insufficient for pneumonia.
Acute Bacterial Rhinosinusitis
For sinusitis, guidelines support either:
- Standard dose: 500 mg TID for mild disease without recent antibiotic use 5
- High dose: 875 mg BID or higher for moderate disease or recent antibiotic exposure 6
Duration of Therapy
Treatment duration should be 10 days for most respiratory infections 1. Key exceptions include:
- Group A strep pharyngitis: minimum 10 days to prevent rheumatic fever 2, 3
- Acute bacterial sinusitis: 5-10 days depending on clinical response 6
- Continue 48-72 hours beyond symptom resolution for all infections 1
Twice-Daily vs Three-Times-Daily Dosing
Research demonstrates that 875 mg BID is as effective as 500 mg TID for lower respiratory tract infections, with potentially better tolerability 7. The BID regimen achieved 93% clinical success versus 94% for TID dosing (not statistically different), but with less diarrhea in the BID group.
For dental infections, one study found 500 mg TID of amoxicillin-clavulanate resulted in greater reduction in inflammatory markers compared to 875 mg BID over 72 hours 8, though this may not apply to amoxicillin monotherapy.
Important Caveats
- Take with food to minimize gastrointestinal intolerance 1
- Renal impairment: Patients with GFR <30 mL/min should NOT receive 875 mg doses; use 500 mg or 250 mg every 12-24 hours depending on severity 1
- Drug resistance considerations: In areas with high penicillin-resistant S. pneumoniae (>10%), higher doses (80-90 mg/kg/day in adults, roughly 2-3 grams daily) may be needed 9
- Compliance: BID dosing improves adherence compared to TID regimens
Bottom Line
While 500 mg TID is FDA-approved and clinically appropriate for mild to moderate infections, 875 mg BID has largely replaced it as the preferred regimen due to equivalent efficacy, better compliance, and similar safety profile. For severe infections or pneumonia, higher total daily doses (2-3 grams) are required regardless of frequency.